ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

ACR Convergence

Keynote Speaker Tait Shanafelt, MD

Keynote Speaker Tait Shanafelt, MD

ACR Convergence 2025, the world’s premier rheumatology experience, is underway this week (Oct. 24–29) in Chicago. This in-person event showcased cutting-edge and timely topics in rheumatology, as well as the prevention, diagnosis and treatment of rheumatic diseases and related comorbid conditions. Check out the video highlights here. Below, you’ll find links to our meeting reports, which will be updated frequently. And don’t miss our expert-curated reports on the top research in lupus nephritis and psoriatic arthritis presented at the meeting.

Focused Content

  • Lupus Nephritis FocusRheum

    Renal biopsy showing class III lupus nephritis with rare foci of subendothelial deposits (wire loop lesions).

    In this commentary by lupus expert Graciela S. Alarcón, MD, MPH, MACR, some of the many abstracts on research into lupus nephritis presented at ACR Convergence 2025 are highlighted. The abstracts selected demonstrate the advances made on the early recognition of the condition, as well as offering some hope in terms of achieving better outcomes. And don’t forget to explore our research reviews, case reports and clinical articles.


    VIEW

  • Psoriatic Arthritis FocusRheum

    What new research on psoriatic arthritis has the potential to impact patient care or future research? Expert and founding editor David S. Pisetsky, MD, PhD, a professor of medicine and integrative immunobiology at Duke University School of Medicine, Durham, N.C., and a staff rheumatologist at the Durham VA Medical Center, curated the research presented at ACR Convergence 2025 and answers that question. You’ll find his commentary and much more in this FocusRheum. 


    VIEW

Previous ACR Meetings

Complete Coverage

Balancing Optimism & Skepticism in CAR T for SLE

At ACR Convergence 2025, Joan T. Merrill, MD, overviewed the current research landscape of chimeric antigen receptor (CAR) T cell therapies for systemic lupus erythematosus (SLE), raising important scientific questions about these emerging treatments.

Incomplete Penetrance in Autoinflammatory Diseases

At this ACR Convergence 2025 session, immunologist Dusan Bogunovic, PhD, discussed his team’s research into how genetic immune diseases manifest with different phenotypes in different people.

Meeting Management Challenges in axSpA

At this ACR Convergence 2025 session, experts discussed emerging concepts with axial spondyloarthritis, including the most effective MRI specifications for diagnosis, challenges with axial juvenile spondyloarthritis & the many mimics of axSpA.

Management of Challenging Cases in Myositis

Immune mediated inflammatory myopathies represent a heterogenous group of diseases with variable degrees of multisystem involvement, including the skin, joints, lungs, and muscles. The ACR Convergence 2025 session, Management of Challenging Cases in Myositis, featured a case-based approach to highlight this complexity, guiding attendees through the nuances of diagnosis and management of antisynthetase syndrome, immune mediated necrotizing myopathy, and dermatomyositis.

From Conceptual Seedling to Tree of Knowledge

In a panel discussion at ACR Convergence 2025, three experts provided insight into how mentorship, personal values and more helped them develop the skills and habits necessary to become a master clinician.